EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

The German ONKOPEDIA Guideline for Myelofibrosis in 2025—Recommendations of an MPN Expert Panel of the German Society for Hematology and Oncology ( DGHO )

Martin Griesshammer, Haifa Kathrin Al-Ali, Gabriela M Baerlocher, Konstanze Döhner, Steffen Koschmieder, Nicolaus Kröger, Petro E Petrides, Dominik Wolf, Florian H Heidel iD

International Journal of Cancer · 01.10.2026 · 159 (7) · 1633-1641

DOI: 10.1002/ijc.70595 ↗

Kurz gefasst

Leitlinie in der Zeitschrift International Journal of Cancer, online erschienen am 21.06.2026. Verfasst von Martin Griesshammer und 8 weiteren Autor:innen. Beteiligte Einrichtung: University Clinic for Hematology, Oncology, Haemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, University of Bochum, Minden…. Hauptthemen laut MEDLINE: Primary Myelofibrosis, Myeloproliferative Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The recently published ONKOPEDIA guideline on myelofibrosis, issued under the auspices of the German Society of Hematology and Oncology (DGHO), provides an updated, evidence‐based framework for the diagnosis and management of this rare, chronic myeloproliferative neoplasm. Developed by a panel of experts (including Germany, Austria and Switzerland) nominated by the DGHO, the guideline reflects a structured and consensus‐oriented process in which internationally recognized specialists in hematology critically reviewed the available evidence, revised the written draft, and engaged in multiple rounds of discussion to ensure consistency, clinical relevance, and scientific rigor. This update builds upon the foundation of the previously available ONKOPEDIA guideline (accessible at www.onkopedia.com ), but extends and refines the recommendations in light of several important recent developments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Primary MyelofibrosisMyeloproliferative DisordersHumansGermanyMedical OncologyHematologySocieties, Medical

Stichwörter der Autor:innen

Myelofibrosisguidelinesrecommendation

Autor:innen und Institutionen

  • University Clinic for Hematology, Oncology, Haemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, University of Bochum, Minden, Germany.
  • Krukenberg Cancer Center, University Hospital of Halle, Halle, Germany.
  • Clinic for Hematology and Oncology, Hirslanden Zürich AG, Zürich, Switzerland.
  • Medica Medical Laboratories and Pathology, Medizinische Laboratorien Dr. F. Kaeppeli AG, Zürich, Switzerland.
  • Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
  • Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.

ORCID-Profile: Florian H Heidel

Zitieren

APA

Griesshammer, M., Al-Ali, H. K., Baerlocher, G. M., Döhner, K., Koschmieder, S., Kröger, N., Petrides, P. E., Wolf, D., & Heidel, F. H. (2026). The German ONKOPEDIA Guideline for Myelofibrosis in 2025—Recommendations of an MPN Expert Panel of the German Society for Hematology and Oncology ( DGHO ). International Journal of Cancer, 159(7), 1633-1641. https://doi.org/10.1002/ijc.70595

Vancouver

Griesshammer M, Al-Ali HK, Baerlocher GM, Döhner K, Koschmieder S, Kröger N, et al. The German ONKOPEDIA Guideline for Myelofibrosis in 2025—Recommendations of an MPN Expert Panel of the German Society for Hematology and Oncology ( DGHO ). International Journal of Cancer. 2026;159(7):1633-1641. doi:10.1002/ijc.70595

BibTeX
@article{Griesshammer2026,
  author = {Griesshammer, Martin and Al-Ali, Haifa Kathrin and Baerlocher, Gabriela M and Döhner, Konstanze and Koschmieder, Steffen and Kröger, Nicolaus and Petrides, Petro E and Wolf, Dominik and Heidel, Florian H},
  title = {The German ONKOPEDIA Guideline for Myelofibrosis in 2025—Recommendations of an MPN Expert Panel of the German Society for Hematology and Oncology ( DGHO )},
  journal = {International Journal of Cancer},
  year = {2026},
  volume = {159},
  number = {7},
  pages = {1633--1641},
  doi = {10.1002/ijc.70595}
}
Kostenlos starten →